Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Int
Starting July 1, 2025, additional opioid overdose response tools will be available to continue addressing evolving patient and customer needs to combat public health crisis Starting July 1, 2025, addi
ABeam Consulting (USA) Ltd. and Millennium EBS Establish Strategic Collaborations to Expedite ISO 20022 Implementation
05:34pm, Wednesday, 25'th Jun 2025
LOS ANGELES, June 25, 2025 (GLOBE NEWSWIRE) -- ABeam Consulting (USA) Ltd. (“ABeam US”) and Millennium EBS , a BlueOne Card Inc. subsidiary, have announced a strategic collaboration under a ne
GAITHERSBURG, Md., June 23, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a $62.4 million contract modification from the Administration for Strat
Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful
02:25pm, Friday, 20'th Jun 2025
Emergent stock is down >40% since my last update. I had given the stock a "Buy" rating but noted that 2025 may be a difficult year. Emergent's MCM business has performed well, but Narcan sales fell dr
Emergent BioSolutions Announces Addition to Russell 3000® Index
08:13am, Friday, 20'th Jun 2025
GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the Company will be added to the broad-market Russell 3000 ® Index, effective after the U
GAITHERSBURG, Md., June 05, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) is teaming up with Victoria's Voice Foundation to rally Americans to help save lives from the opioid epidemi
5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost
10:55am, Thursday, 29'th May 2025
Broker-favored picks like BYON, BTSG, ACDVF, EBS, and ADNT are worth monitoring amid EU tariff delay and rising consumer confidence.
5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes
11:55am, Friday, 16'th May 2025
Investors would do well to monitor broker-favored stocks like BTSG, BYON, ACDVF, DINO, and EBS for high returns.
Emergent BioSolutions to Participate in Upcoming Investor Conferences
07:32am, Wednesday, 14'th May 2025
GAITHERSBURG, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of its executive management team will participate in the following investor conf
Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript
10:01pm, Wednesday, 07'th May 2025
Emergent BioSolutions Inc. (NYSE:EBS ) Q1 2025 Earnings Call May 7, 2025 5:00 PM ET Company Participants Frank Vargo - Vice President, Assistant Treasurer Joe Papa - President and Chief Executive Offi
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates
06:41pm, Wednesday, 07'th May 2025
Emergent Biosolutions (EBS) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.59 per share a year ago.
Emergent BioSolutions Reports First Quarter 2025 Financial Results
04:05pm, Wednesday, 07'th May 2025
First Quarter 2025 Total Revenues of $222.2 million, decrease of 26% versus prior year First Quarter 2025 Net Income of $68.0 million, increase of 656% versus prior year First Quarter 2025 Gross Margi
Agreement will facilitate widespread distribution of NARCAN® Nasal Spray throughout Ontario Agreement will facilitate widespread distribution of NARCAN® Nasal Spray throughout Ontario
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
08:00am, Tuesday, 22'nd Apr 2025
GAITHERSBURG, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 7, 2025, at 5:00 pm eastern time to discuss the financial res
